Here we assess the intrinsic functions of the chemokine receptor CXCR4 in remodeling after myocardial infarction (MI) using Cxcr4 heterozygous (Cxcr4 ϩ/Ϫ ) mice.
interaction between CXCL12 and CXCR4 is increasingly exploited to enhance the efficacy of stem cell therapy after myocardial infarction (MI) (4) . Exogenous CXCL12 applied by myocardial injection or overexpressed in transplanted cardiomyocytes, as well as overexpression of CXCR4 in mesenchymal stem cells, induces therapeutic angiogenic/progenitor cell homing (5-7), increasing capillary density and improving cardiac function after MI (8, 9) . On the other hand, CXCL12 directly activates the cellsurvival factor protein kinase B (PKB/Akt) via CXCR4 and protects ischemic myocardium, decreasing scar formation and mediating neovascularization in mice and rats (10, 11) .
The intrinsic role of endogenous CXCL12/CXCR4 in MI, however, is far from being conclusively elucidated. For instance, administration of the selective CXCR4 antagonist AMD3100 reduced scar formation and improved cardiac contractility after MI (12) . Moreover, CXCL12 can induce both survival and apoptotic signals via CXCR4, which may ultimately determine the fate of afflicted tissues (13) . We therefore studied the function of CXCR4 in cardiac remodeling after MI in genetically modified mice to evaluate a potential relevance for unwanted effects of pharmacologic compounds (14) . However, mice deficient in Cxcr4 display profound defects in the hematopoietic and nervous systems and die perinatally. They have severely reduced B-lymphopoiesis, myelopoiesis in fetal liver, and a virtual absence of myelopoiesis in bone marrow (15) . Therefore, we chose to assess the effects of reduced CXCR4 expression after MI in mice heterozygous for CXCR4 (Cxcr4 ϩ/Ϫ ), which appear normal and are viable and fertile (15) , although CXCR4 surface expression on bone marrow-derived mononuclear cells from Cxcr4 ϩ/-mice is significantly lower compared with that in wild-type BL6/J mice (16) .
Methods
For the mouse model of MI and details of other methods (e.g., reverse transcriptase polymerase chain reaction analysis [Online Table 1 ]), please see the Online Appendix.
Results
Analysis of MI size and inflammatory cell content. Four weeks after MI, the infarct size was reduced in Cxcr4 ϩ/Ϫ mice by 42% compared with Cxcr4 ϩ/ϩ littermates (Fig. 1A) . As evident by tetrazolium/Evans blue staining, the area at risk 1 day after MI showed no difference in the 2 groups (Online Fig. 1A ), indicating that the reduced infarct size likely reflects an enhanced wound contraction and alterations in reparative pathways rather than a difference in the initial extent of cardiomyocyte injury. Moreover, myofibroblast infiltration (2,600 Ϯ 283/mm 2 vs. 1 011 Ϯ 165/mm 2 in controls, p Ͻ 0.001) and collagen content in the infarcted area were significantly higher in Cxcr4 ϩ/Ϫ mice than in wild-type controls (Fig. 1B) , indicating a more stable and robust scar formation. We next analyzed the mobilization and recruitment of inflammatory cells after MI. The MI-induced and transient expansion of neutrophils in the circulation (Fig. 1C) and infiltration of the infarcted area with neutrophils ( Fig. 1D) were severely reduced in Cxcr4 ϩ/Ϫ mice 1 day after MI. Thus, the initial inflammatory response differed markedly in Cxcr4 ϩ/Ϫ mice, indicating a prominent role of CXCR4 in post-infarction neutrophil recruitment. Further, peripheral blood monocyte levels did not differ between Cxcr4 ϩ/Ϫ mice and wild-type mice after MI (Online Fig. 1B) , whereas the myocardial infiltration with monocytes/macrophages presented a slight delay in Cxcr4 ϩ/Ϫ mice compared with wild-type mice (Online Fig. 1C) .
Analysis of monocyte subsets revealed fewer circulating Gr-1 high cells and relative expansion of Gr-1 low cells in peripheral blood of Cxcr4 ϩ/Ϫ mice compared with wild-type mice after MI (Fig. 1E ). These data correspond to diminished infiltration with proinflammatory tissue-degrading Gr-1 high monocytes 4 days after MI, whereas Gr-1 low monocytes, known to promote wound healing and collagen deposition (17) , were increased in the hearts of Cxcr4 ϩ/Ϫ mice compared with wild-type mice (Fig. 1F) . Thus, the inflammatory reaction after MI in Cxcr4 ϩ/Ϫ mice is shifted to an earlier termination of the acute response and onset of a repair process involving Gr-1 low monocytes. Notably, whereas CXCR4 expression on Gr-1 low monocytes from Cxcr4 ϩ/Ϫ mice (specific mean fluorescence intensity, 31.5 Ϯ 3.0) was reduced by 43% compared with that on Gr-1 low monocytes from wild-type mice (specific mean fluorescence intensity, 61.9 Ϯ 7.4), the low CXCR4 expression on Gr-1 high monocytes did not differ between wild-type mice and Cxcr4 ϩ/Ϫ mice (specific mean fluorescence intensity, 6.8 Ϯ 3.5 vs. 5.2 Ϯ 1.5). This suggests a strong adaptation of Gr-1 low cells to reduced CXCR4 expression and a possible role of other receptors in their recruitment. Analysis of cardiac function after MI. Echocardiography (Online Table 2 ) and Langendorff ( Table 2 , Fig. 2A ). To assess whether defective cardiac angiogenesis and neovascularization after MI contribute to the differences in coronary blood flow, myocardial endothelial cells and vessels were quantified. As determined by flow cytometry, the number of myocardial endothelial cells was intrinsically reduced in Cxcr4 ϩ/Ϫ mice compared with wild-type mice (Fig. 2C) . Similarly, neovascularization after MI was impaired in Cxcr4 ϩ/Ϫ mice compared with wild-type mice, as evident by reduced formation of CD31 ϩ blood vessels in infarcted myocardium (Fig. 2D ). This might contribute to the defective recovery of coronary flow after MI in Cxcr4 ϩ/Ϫ mice. Moreover, the number of primary branches of coronary arteries ( Fig.  2E ) as shown by micro-angio-computed tomography, as well as the number of cremasteric artery branches as quantified by intravital microscopy (data not shown) was diminished in
Cxcr4
ϩ/Ϫ mice compared with wild-type mice without evidence of disturbed endothelial permeability, as shown by perfusion of the cremasteric artery with albumin-fluorescein isothiocyanate. This indicates that the endogenous defect in angiogenesis was not restricted to the heart. Moreover, to distinguish the influence of the CXCR4 heterozygous background and its role in circulating cells, bone marrow chimera experiments were performed after lethal irradiation. Four weeks after MI, the infarction area was significantly reduced in wild-type mice transplanted with Cxcr4 ϩ/Ϫ bone marrow and in Cxcr4 ϩ/Ϫ mice transplanted with wild-type bone marrow compared with the control group (Fig. 3A) . In addition to the effects attributable to reduced leukocyte infiltration, these data suggest the existence of an additional intrinsic mechanism that can substantially influence scar formation in our model. Notably, neovascularization after MI was impaired in both groups compared with controls, as evident by CD31 ϩ staining in infarcted myocardium (Fig. 3B) , whereas heart function, as assessed by Liehn et al. November 29, 2011 November 29, :2415 CXCL12/CXCR4 Axis in Myocardial Infarction echocardiography and Langendorff perfusion showed no significant differences between the groups (Fig. 3C ). The reduction of neovascularization was more pronounced in Cxcr4 ϩ/Ϫ mice transplanted with wild-type bone marrow and correlated with decreased coronary flow (Fig. 3D ). This may reflect that the vascularization of the scar is based mostly on vessel formation around pre-existing collaterals, which may explain the markedly reduced neovascularization in Cxcr4 ϩ/Ϫ mice despite reconstitution with wild-type bone marrow.
The myocardial infiltration with neutrophils, as well as blood leukocyte subsets (Fig. 3E) 
in Cxcr4 ϩ/Ϫ mice, indicating a shift toward an earlier termination of the acute response and earlier onset of a repair process. The role of CXCR4 for early outgrowth cells trafficking and function. Because early outgrowth cells (EOCs) contribute to post-infarction neoangiogenesis, the effect of Cxcr4 on EOC function was studied. Despite endotheliumlike properties of both Cxcr4 ϩ/Ϫ EOCs and wild-type EOCs, the function of Cxcr4 ϩ/Ϫ EOCs was impaired, as shown in chemotaxis or Matrigel assays in vitro and in vivo. (Online Fig. 2 ). For more details, see the Online Appendix. Myocardial apoptosis after MI. No difference in myocardial apoptosis after induction of MI was observed in Cxcr4 ϩ/Ϫ mice and wild-type mice after MI, as assessed by quantifying TUNEL (deoxyuride-5=-triphosphate biotin nick end labeling)-positive cells and by reverse transcriptase polymerase chain reaction for Bax and Bcl2 expression (Online Fig. 3 ). For more details, please see the Online Appendix. Electron microscopy and characterization of lipid extracts. To detect structural alterations, we performed electron microscopy in the hearts of the Cxcr4 ϩ/Ϫ mice and wild-type mice before or 1 day after MI. Wild-type myocardium displayed extensive signs of necrosis with dramatic cellular disintegration (Fig. 4A) .
In infarcted Cxcr4
ϩ/Ϫ myocardium, signs of myofibril disorganization, and cardiomyocyte swelling were present, but cellular structures were still distinguishable (Fig. 4A) . Notably, in uninjured Cxcr4 ϩ/Ϫ myocardium, we found atypical lipofuscin-like lipid accumulations with strong osmium tetroxide fixation (Fig. 4A) , likely containing long-chain monounsaturated fatty acids and resembling those found after dietary fish oil feeding, known to reduce ischemic damage in rat hearts (18, 19) .
Subsequent lipid extraction and high-performance liquid chromatography analysis indicated a marked accumulation of phosphatidylserine (PS) (fractions 1 to 3) in Cxcr4 ϩ/Ϫ mouse hearts, which is not present in the hearts of wild-type mice (Fig. 4B) . Using gas chromatography, we analyzed the unsaturated fatty acid index of cardiac lipid extracts (triglyceride, phosphatidylcholine/ethanolamine, PS). The triglyceride fraction obtained from Cxcr4 ϩ/Ϫ mouse hearts contained 10% more unsaturated fatty acids than wild-type mouse hearts, and 6 different unsaturated fatty acids appeared in the triglyceride fraction of Cxcr4 ϩ/Ϫ hearts. No differences were noted for saturated/unsaturated fatty acid content in phosphatidylcholine or ethanolamine. The fatty acid composition of the 3 PS fractions is detailed in Online Table 3 .
To evaluate a potential contribution of the PS fractions to cardioprotection in Cxcr4 ϩ/Ϫ mice, isolated cardiomyocytes were pre-incubated with the PS fractions 1, 2, or 3 for 3 h, and the response to hypoxic stress was analyzed. As evident by dihydroethidium staining to monitor radical formation, all PS fractions protected cardiomyocytes against hypoxic injury (Fig. 4C) . Notably, PS fraction 1 with the highest percentage of saturated fatty acids offered the best protection against hypoxic injury. These data indicate that Cxcr4 ϩ/Ϫ mouse hearts are intrinsically adapted to hypoxic injury. 
Discussion
Our data demonstrate the double-edged effects of CXCR4 on myocardial remodeling after MI and point to a variety of possible mechanisms with major clinical implications. Compared with wild-type mice, Cxcr4 ϩ/Ϫ mice revealed smaller and stable MI scars due to an attenuation of the acute inflammatory recruitment of neutrophils, a shift toward a more regenerative monocyte response, and better adaptation of cardiomyocytes to hypoxic stress. This was balanced by impaired EOC function, myocardial neovascularization, and coronary flow recovery, overall amounting to a lack of improvement in ventricular function. Given the major efforts to exploit the CXCL12/CXCR4 axis therapeutically to promote angiogenesis and cellular regeneration, our data provide important insights into endogenous function of CXCR4 after MI.
First, we found an altered inflammatory pattern in Cxcr4 ϩ/Ϫ mice after MI characterized by diminished neutrophils and tissue-degrading Gr1 high monocytes, myocardial infiltration, and earlier infiltration with Gr1 low monocytes, followed by collagen deposition (17) . Reduced neutrophil infiltration itself may substantially affect myocardial injury and reduce MI size (20, 21) by reducing the release of reactive oxygen species, proteases, and inflammatory mediators. Recently, CXCR4 was identified as a central regulator of neutrophil homeostasis directing their release from bone marrow under stress conditions (20) . Although complete disruption or deficiency of CXCR4 caused an expansion of less mature neutrophils in the circulation in the chronic context of atherogenesis (22), we found that an acute mobilization of neutrophils was blocked by the potent CXCR4 antagonist AMD3645 (23) . Similarly, we observed that MI caused an acute expansion of circulating neutrophils and their myocardial recruitment, which was attenuated in Cxcr4 ϩ/Ϫ mouse hearts. This is in line with a recent study that failed to detect neutrophil mobilization after various forms of stimulation or infection when CXCR4 signaling was abrogated (20) . Thus, our data confirm a role of CXCR4 in injury-or stress-induced neutrophil mobilization, allowing their subsequent recruitment.
Monocytes play an important and finely tuned role in cardiac repair (17) . We found that after MI, overall monocyte/macrophage infiltration into the myocardium was delayed in Cxcr4 ϩ/Ϫ mice owing to a reduced infiltration with Gr-1 high inflammatory monocytes during the initial phase, in a process that may be governed by neutrophil secretory products (24, 25) . Preventing Gr-1 high monocytosis results in a delayed or inefficient removal of apoptotic cells and necrotic tissue but does not impede healing (17, 26) . Conversely, Gr-1 low monocytes, which promote healing via myofibroblast accumulation and collagen deposition, were more prevalent and recruited earlier after MI in Cxcr4 ϩ/Ϫ mice. This shift to a more robust repair may contribute to smaller and stable scar formation. Interestingly, we found that Gr-1 high monocytes from Cxcr4 ϩ/Ϫ mice did not display reduced CXCR4 expression. Whereas one may hypothesize that the reparative Gr-1 cells uses additional receptors to compensate for lower CXCR4 levels in recruitment, these data generally imply an important role of other receptors, namely, CCR2, in the recruitment of Gr-1 high monocytes. Despite reduced MI size, ventricular function was not significantly improved in Cxcr4 ϩ/Ϫ mice. This could be due to the reduced basal coronary flow and to the impaired coronary flow recovery in Cxcr4 ϩ/Ϫ hearts 4 weeks after MI. As an underlying mechanism, we studied the function of EOCs as important contributors to neovascularization after MI. The SDF-1/Cxcr4 interaction is crucially involved in the mobilization and recruitment of stem and progenitor cells to the heart after MI (5, 27) . Despite appropriate acquisition of typical endothelial differentiation markers, splenic EOCs from Cxcr4 ϩ/Ϫ mice showed deficient chemotaxis toward CXCL12 (but not vascular endothelial growth factor) and reduced tube formation in vitro. Accordingly, myocardial vessel density, endothelial cell content, vessel invasion in Matrigel and arterial branching in vivo was impaired in Cxcr4 ϩ/Ϫ mice. This is in keeping with a previous study showing that EOCs from Cxcr4 ϩ/Ϫ mice were also significantly impaired to restore blood flow in ischemic nude mice compared with wild-type EOCs in the hindlimb ischemia model (16) . Although we show in vitro that these effects are mostly due to a dysfunction of EOCs, we cannot exclude that a decrease in surrounding vascular density also plays a supportive role in our in vivo models through reducing the number of circulating cells available at the site of injury. Conversely, a lack of functional improvement in Cxcr4 ϩ/Ϫ mice cannot be explained by a modulation of cardiomyocyte contractility by CXCR4 because CXCL12 has been shown to exert negative inotropic effects (28) so that one would rather expect improved ventricular function on inhibition of Cxcr4 deficiency.
Moreover, we performed bone marrow chimera experiments to distinguish the influence of the Cxcr4 heterozygous background and its effect on circulating cells in normally developed wild-type mice. Despite a reconstitution with wild-type bone marrow, a reduction of infarction area and neovascularization persisted in Cxcr4 ϩ/Ϫ mice. Moreover, a significant, albeit less marked, reduction was observed in wild-type mice reconstituted with Cxcr4 ϩ/Ϫ bone marrow, indicating that reduced CXCR4 levels on circulating cells (namely, progenitor cells and leukocytes) may also contribute to the effects observed after MI in Cxcr4 heterozygous mice, independently of their abnormal cardiovascular development.
Notably, the reduced basal and neovascularization of Cxcr4 ϩ/Ϫ hearts without any sign of physiologic dysfunction raises several questions. Diminished blood supply should lead to a series of histopathologic and structural changes of the myocardium with an increase in cardiomyocyte apoptosis, ventricular mass and volume, and progressive decline in left ventricular performance. None of these parameters, however, differ in Cxcr4 ϩ/Ϫ mice. Moreover, recent data indicate that CXCR4 expression on cardiomyocytes is not essential for cardiac development and has no major role in ventricular remodeling after MI (29) . Because Cxcr4 ϩ/Ϫ myocardium is spared and hypoxic injury seems to be less extensive, compared with that in wild-type mice, we assume that the protective mechanism in Cxcr4 ϩ/Ϫ myocardium is mostly due to adaptive changes during embryogenesis. Using electron microscopy, we observed lipofuscin-like lipid accumulations, which resembled those found in rat hearts after dietary fish oil feeding (18) . A diet enriched with n-3 fatty acids can reduce ischemic damage to the heart (30) and may represent a possible lead to protection, but this clearly requires further investigation into underlying mechanisms.
Another notable difference in the lipid extracts of Cxcr4 ϩ/Ϫ myocardium is the high levels of PS, generally known as a marker of cell death (31) . However, PS supports other cell functions, including mitochondrial membrane integrity and activation of protein kinase C, which is important in hypoxia tolerance during late preconditioning (32) , as well as in the inhibition of specific immune responses (33) . In our study, the permanently decreased coronary flow in Cxcr4 ϩ/Ϫ mice may induce a chronic ischemia and thus may force cardiomyocytes to adapt even from early stages of embryonic development. An increase in 2421 JACC Vol. 58, No. 23, 2011 Liehn et al. November 29, 2011 November 29, :2415 CXCL12/CXCR4 Axis in Myocardial Infarction cardiac PS seems to be a possible cause mediating this adaptive mechanism because pre-incubation of cardiomyocytes with PS isolated from Cxcr4 ϩ/Ϫ mouse hearts protected cardiomyocytes against hypoxic injury. However, the exact mechanism remains to be established.
Extensive attempts have been made to directly affect the CXCL12/CXCR4 axis (e.g., by direct injection, nanofibermediated delivery of CXCL12, or overexpression of CXCL12/CXCR4 in cells transplanted into the myocardium (5-11), aiming to reduce MI size and to improve ventricular function after MI. The double-edged effects of CXCR4 are illustrated by an alteration of the inflammatory response and protection against hypoxic stress, as well as impaired EOC function, neovascularization, and coronary flow recovery. Pharmacologic antagonism of CXCR4 with AMD3100 has been reported to reduce infarct size and to improve ventricular function after MI in rats (12) . Although the decrease in MI size is consistent with our findings, an improved contractility has been explained by a suppression of the hypertrophic response in the noninfarct area. This differs from Cxcr4 ϩ/Ϫ mice, which have intrinsically reduced coronary flow and can be considered as a model for congenitally impaired vascularization and adaptation to hypoxia.
Limitations and Conclusions
Although studies in bone marrow chimeras suggested a role of CXCR4 on cells infiltrating from the circulation in explaining the reduction in infarct size, one notable limitation of our study is clearly the lack of mice with specific and inducible deletion of CXCR4 in either circulating cells or resident myocardial cells to better dissect the underlying mechanisms. In addition, caution should be exerted when extrapolating these results to an inhibition of CXCR4 in the human system. Nevertheless, cell-specific, contextdependent, and long-term effects of CXCR4 interference or CXCL12 application need to be carefully taken into account when devising therapeutic strategies for MI and ischemic cardiomyopathy.
